NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Komen said:

Also, no one really mentioned anything about the possibility of the number of subset patient group analysis built into this trial that may be causing the delay in the interim analysis. Anyone know what the predetermined subgroups are?

-- Komen

Actually, there has been a great deal of hypothetical analysis on these points during the month of February on this board. I humbly recommend you read through them all, as several posters contributed thoughts, questions, constructive criticisms, etc. You can't always expect all the posts will be connected in a thread; so you really need to go through the month of February. Its requires a lot of reading. If I gave you cliff notes, I'd be doing a disservice to everyone's contributions. Plus, it would be a lot of work.